Tag: Pfizer-BioNTech Vaccine

  • COVAX: How Nigeria Received Over 20 Million Doses In Two Years

    COVAX: How Nigeria Received Over 20 Million Doses In Two Years

    On the night of Feb. 27, 2020, Nigeria reported its first case of COVID-19 in the country. The case was an Italian citizen who works in Nigeria and returned from Milan, Italy to Lagos, Nigeria on the 25th of February 2020. He was confirmed by the Virology Laboratory of the Lagos University Teaching Hospital, part…

  • Pfizer Confirms Third Vaccine Shots Can Neutralize Omicron Variant

    Pfizer Confirms Third Vaccine Shots Can Neutralize Omicron Variant

    BioNTech and Pfizer (PFE.N) have confirmed that a three-shot course of their COVID-19 vaccine is able to neutralize the new Omicron variant following results from recent laboratory tests. The German and U.S. companies said two doses of their vaccine resulted in significantly lower neutralising antibodies but could still be protective against severe disease. “The first line of…

  • BioNTech Says Malaria Vaccine Is in Production

    BioNTech Says Malaria Vaccine Is in Production

    German drugmaker BioNTech has announced its new production of an mRNA-based vaccine to prevent malaria, the longstanding disease that has affected millions of people in Africa and other parts of the world. The company, which developed America’s first authorized coronavirus vaccine with U.S. pharmaceutical company Pfizer, said clinical trials shots would begin by the end of 2022.…

  • Pfizer To Begin Vaccine Production In South Africa

    Pfizer To Begin Vaccine Production In South Africa

    Pfizer and BioNTech laboratories have begun the process of partially producing Covid-19 vaccines in South Africa to bridge vaccine scarcity in Africa. In a statement detailing the alliance’s first partnership outside Europe and North America, Biotech explained that they had partnered with Pfizer and Biovac Group, intending to supply up to 100 million doses per…

  • Facts About The South African Coronavirus Variant

    Facts About The South African Coronavirus Variant

    First detected in South Africa, the B.1.351 of the SARS-CoV-2 virus has spread to dozens of countries around the world. Fact Check The B.1.351 is not a different virus. As the SARS-CoV-2 virus spreads around the world, it constantly mutates which leads to the emergence of new strains. The B.1.351 is a variant of the coronavirus.…

  • Rwanda Becomes First African Country To Receive Pfizer Vaccine

    Rwanda Becomes First African Country To Receive Pfizer Vaccine

    On Wednesday, February 3, 2020, Rwanda became the first African country to receive the Pfizer-BioNTech coronavirus vaccine from the COVAX initiative. According to the Ministry of Health, a flight carrying 240,000 doses of the AstraZeneca/Oxford vaccine produced by the Serum Institute of India landed at the Kigali International Airport in the morning hours of Wednesday…

  • Pfizer-BioNTech Claim Vaccines Are Effective Against UK COVID-19 Variant

    Pfizer-BioNTech Claim Vaccines Are Effective Against UK COVID-19 Variant

    A recently published research paper by Pfizer and partner BioNTech is claiming its coronavirus vaccine is likely to be highly effective against the UK COVID-19 variant. The variant also known as B.1.1.7, has caused alarm among experts because of its increased ability to spread and supercharge virus outbreaks. Pfizer research paper which has not been subjected to…

  • Canada Slows Vaccination Over Delayed Delivery From Pfizer

    Canada Slows Vaccination Over Delayed Delivery From Pfizer

    Federal officials have revealed that only half of Canada’s promised COVID-19 vaccine doses by Pfizer-BioNTech will arrive in the next month as a result of production issues in Belgium. Saskatchewan Premier Scott Moe, has expressed concerns over the delay saying the province’s strategy for the two-dose regime depends on steady shipments even though the Prime…